HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Neurobehavioral Dysfunction in Substance Dependence
Neurobehavioral Dysfunction in Substance Dependence
Substance dependence disrupts neurobehavioral processes, leading to impairments in reward perception, emotional regulation, and impulse control. Drugs hijack the brain’s reward system, causing an overproduction of dopamine and reinforcing compulsive behaviors. Long-term use alters brain structure, particularly in areas like the prefrontal cortex and amygdala, affecting decision-making and stress response. Behavioral therapies, such as CBT and contingency management, aim to rewire these dysfunctional circuits. Combined with medication-assisted treatment, these approaches address both neurochemical imbalances and maladaptive behaviors. Recovery requires a comprehensive understanding of the neurobehavioral underpinnings of addiction.
Committee Members
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain GAB 2025 Speakers
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States